Lilly picks AmerisourceBergen for commercial rollout of COVID antibody therapy (NYSE:LLY)
Eli Lilly (LLY) announced that the FDA had updated the authorization granted for its COVID-19 antibody therapy bebtelovimab allowing its commercial availability from next week through…
Lilly picks AmerisourceBergen for commercial rollout of COVID antibody therapy (NYSE:LLY)
Eli Lilly (LLY) announced that the FDA had updated the authorization granted for its COVID-19 antibody therapy bebtelovimab allowing its commercial availability from next week through…